Riik: Uus-Meremaa
keel: inglise
Allikas: Medsafe (Medicines Safety Authority)
Boceprevir 200mg
Merck Sharp & Dohme (New Zealand) Limited
Boceprevir 200 mg
200 mg
Capsule
Active: Boceprevir 200mg Excipient: Capsugel yellow 2276 Capsugel yellow 4077 Croscarmellose sodium Lactose monohydrate Magnesium stearate Microcrystalline cellulose Pregelatinised maize starch Sodium laurilsulfate Tekprint red SB-1100
Blister pack, PVC/PCTFE/Al blisters x84/carton x4 cartons, 336 capsules
Prescription
Prescription
MSD International GmbH (Singapore Branch)
Victrelis (boceprevir) is indicated for the treatment of Chronic Hepatitis C (HCV) genotype 1 infection, in a combination regimen with peginterferon alpha and ribavirin, in adult patients (18 years and older) with compensated liver disease who are previously untreated or who have failed previous therapy.
Package - Contents - Shelf Life: Blister pack, PVC/PCTFE/Al blisters x84/carton x4 cartons - 336 capsules - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) protect from light and moisture 3 months opened stored at or below 30°C protect from light and moisture
2012-01-31
Page 1 VICTRELIS ® CAPSULES _Boceprevir _ CONSUMER MEDICINE INFORMATION What is in this leaflet? This leaflet answers some common questions about VICTRELIS Capsules. It does not contain all of the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you using VICTRELIS Capsules against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT USING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may want to read it again. What VICTRELIS is used for? VICTRELIS Capsules contain a medicine called boceprevir. VICTRELIS stops the multiplication of the hepatitis C virus. VICTRELIS works by lowering the amount of Hepatitis C Virus in your body. VICTRELIS Capsules must only be used in combination with two other medicines (peginterferon alfa and ribavirin) for the treatment of chronic hepatitis C Type 1 virus infection in adults. Peginterferon alfa belongs to a group of medicines called interferons. Ribavirin is an antiviral agent. Combination therapy with VICTRELIS Capsules is used for the treatment of chronic hepatitis C (a viral infection of the liver) Type 1 in patients (18 years or older) who have compensated liver disease and who either have not previously received, or have failed, interferon alfa treatment (pegylated or nonpegylated). Before you use VICTRELIS Capsules SINCE VICTRELIS MUST BE TAKEN IN COMBINATION WITH PEGINTERFERON ALFA AND RIBAVIRIN, CERTAIN WARNING IN THIS CONSUMER MEDICINE INFORMATION ARE DETAILED HERE BECAUSE THEY RELATE TO VICTRELIS OR PEGINTERFERON ALFA OR RIBAVIRIN. _When you must not use it: _ DO NOT USE VICTRELIS CAPSULES IF YOU ARE ALLERGIC TO BOCEPREVIR OR ANY OF THE ING Lugege kogu dokumenti
Ref: LRN 503034-BCV-CP-USPI-1; LRN 503034-BCV-CP-CCDS-3 A120726 v1.0 Page 1 of 25 NEW ZEALAND DATA SHEET VICTRELIS ® (BOCEPREVIR) CAPSULES NAME OF THE MEDICINE VICTRELIS Boceprevir has the following structural formula: N H N HN O O H N O NH 2 O O CAS registry number: 394730-60-0 Boceprevir has the following chemical name: (1R,5S)-N-[3-Amino-1-(cyclobutylmethyl)-2,3- dioxopropyl]-3-[2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6- dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide. The molecular formula is C 27 H 45 N 5 O 5 and its molecular weight is 519.7. DESCRIPTION VICTRELIS (boceprevir) is an inhibitor of the Hepatitis C virus (HCV) non-structural protein 3 (NS3) serine protease. Boceprevir is manufactured as an approximately equal mixture of two diastereomers. Boceprevir is a white to off-white amorphous powder. It is freely soluble in methanol, ethanol and isopropanol and slightly soluble in water with a partition coefficient (logP octanol/water ) of 3.0. _ _ VICTRELIS 200 mg capsules are available as hard gelatin capsules for oral administration. Each capsule contains 200 mg of boceprevir and the following inactive ingredients: sodium lauryl sulfate, microcrystalline cellulose, lactose monohydrate, croscarmellose sodium, pre-gelatinized starch, and magnesium stearate. The yellowish-brown opaque cap consists of gelatin, E172 Red Iron Oxide, E172 Yellow Iron Oxide and titanium dioxide. The off-white opaque body contains gelatin, titanium dioxide and E172 Yellow Iron Oxide. The capsule is printed in red ink (Red SB-1100). The red ink contains Shellac, Ph.Eur., Ethanol anhydrous, Ph.Eur., Isopropyl alcohol _ _ PHARMACOLOGY PHARMACODYNAMIC PROPERTIES A direct-acting antiviral for treatment of Chronic Hepatitis C._ _ Ref: LRN 503034-BCV-CP-USPI-1; LRN 503034-BCV-CP-CCDS-3 A120726 v1.0 Page 2 of 25 Mechanism of action VICTRELIS is an inhibitor of the HCV NS3 protease. VICTRELIS covale Lugege kogu dokumenti